Abstract
The field of stem cell biology and regenerative medicine is rapidly moving toward translation to clinical practice, and in doing so has become more dependent on animal donors and hosts for generating cellular reagents and assaying their potential therapeutic efficacy in models of human disease. Animal models of cardiovascular disease have proved critically important for the discovery of pathophysiological mechanisms and for the advancement of diagnosis and therapy. They offer a number of advantages; principally the availability of adequate healthy controls and the absence of confounding factors such as marked differences in age, concomitant pathologies, and pharmacological treatments. Over the past 30 years, investigators have developed numerous small and large animal models to study heart failure (HF). However, to translate discoveries from basic science into medical applications, research in large animal models becomes a necessary step. Intracoronary microembolizations-induced HF in dogs is an excellent large animal model of congestive HF for the assessment of pharmacological drugs, medical devices, and stem cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hasenfuss, G. (1998) Animal models of human cardiovascular disease, heart failure and hypertrophy, Cardiovasc Res 39, 60–76.
Rastogi, S., Gupta, R. C., Mishra, S., Morita, H., and Sabbah, H. N. (2002) Long term therapy with Acorn cardiac support device normalizes gene expression of alfa and beta myosin heavy chain in dogs with chronic heart failure, Circulation 106(19), II–384 Abstract.
Sabbah, H. N., Stein, P. D., Kono, T., Gheorghiade, M., Levine, T. B., Jafri, S., Hawkins, E. T., and Goldstein, S. (1991) A canine model of chronic heart failure produced by multiple sequential coronary microembolizations, Am J Physiol 260, H1379–H1384.
Morita, H., Suzuki, G., Mishima, T., Chaudhry, P. A., Anagnostopoulos, P. V., Tanhehco, E. J., Sharov, V. G., Goldstein, S., and Sabbah, H. N. (2002) Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure, Cardiovasc Drugs Ther 16, 443–449.
Sabbah, H. N., Shimoyama, H., Kono, T., Gupta, R. C., Sharov, V. G., Scicli, G., Levine, T. B., and Goldstein, S. (1994) Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction, Circulation 89, 2852–2859.
Suzuki, G., Morita, H., Mishima, T., Sharov, V. G., Todor, A., Tanhehco, E. J., Rudolph, A. E., McMahon, E. G., Goldstein, S., and Sabbah, H. N. (2002) Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure, Circulation 106, 2967–2972.
Tanimura, M., Sharov, V. G., Shimoyama, H., Mishima, T., Levine, T. B., Goldstein, S., and Sabbah, H. N. (1999) Effects of AT1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failure, Am J Physiol 276, H1385–H1392.
Kono, T., Sabbah, H. N., Rosman, H., Alam, M., Stein, P. D., and Goldstein, S. (1992) Left atrial contribution to ventricular filling during the course of evolving heart failure, Circulation 86, 1317–1322.
Gengo, P. J., Sabbah, H. N., Steffen, R. P., Sharpe, J. K., Kono, T., Stein, P. D., and Goldstein, S. (1992) Myocardial beta adrenoceptor and voltage sensitive calcium channel changes in a canine model of chronic heart failure, J Mol Cell Cardiol 24, 1361–1369.
Sabbah, H. N., Kono, T., Rosman, H., Jafri, S., Stein, P. D., and Goldstein, S. (1992) Left ventricular shape: a factor in the etiology of functional mitral regurgitation in heart failure, Am Heart J 123, 961–966.
Sabbah, H. N., Kono, T., Stein, P. D., Mancini, G. B., and Goldstein, S. (1992) Left ventricular shape changes during the course of evolving heart failure, Am J Physiol 263, H266–H270.
Sabbah, H. N., Goldberg, A. D., Schoels, W., Kono, T., Webb, C., Brachmann, J., and Goldstein, S. (1992) Spontaneous and inducible ventricular arrhythmias in a canine model of chronic heart failure: relation to haemodynamics and sympathoadrenergic activation, Eur Heart J 13, 1562–1572.
Kono, T., Rosman, H., Alam, M., Stein, P. D., and Sabbah, H. N. (1993) Hemodynamic correlates of the third heart sound during the evolution of chronic heart failure, J Am Coll Cardiol 21, 419–423.
Sabbah, H. N., Hansen-Smith, F., Sharov, V. G., Kono, T., Lesch, M., Gengo, P. J., Steffen, R. P., Levine, T. B., and Goldstein, S. (1993) Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failure, Circulation 87, 1729–1737.
Sabbah, H. N., Sharov, V., Riddle, J. M., Kono, T., Lesch, M., and Goldstein, S. (1992) Mitochondrial abnormalities in myocardium of dogs with chronic heart failure, J Mol Cell Cardiol 24, 1333–1347.
Sabbah, H. N., Levine, T. B., Gheorghiade, M., Kono, T., and Goldstein, S. (1993) Hemodynamic response of a canine model of chronic heart failure to intravenous dobutamine, nitroprusside, enalaprilat, and digoxin, Cardiovasc Drugs Ther 7, 349–356.
Rastogi, S., Imai, M., Sharov, V. G., Mishra, S., and Sabbah, H. N. (2008) Darbepoetin alfa prevents progressive left ventricular dysfunction and remodeling in non-anemic dogs with heart failure, Am J Physiol Heart Circ Physiol 295, H2475–H2482.
Rastogi, S., Mishra, S., Zaca, V., Alesh, I., Gupta, R. C., Goldstein, S., and Sabbah, H. N. (2007) Effect of long-term monotherapy with the aldosterone receptor blocker eplerenone on cytoskeletal proteins and matrix metalloproteinases in dogs with heart failure, Cardiovasc Drugs Ther 21, 415–422.
Rastogi, S., Mishra, S., Zaca, V., Mika, Y., Rousso, B., and Sabbah, H. N. (2008) Effects of chronic therapy with cardiac contractility modulation electrical signals on cytoskeletal proteins and matrix metalloproteinases in dogs with heart failure, Cardiology 110, 230–237.
Rastogi, S., Sentex, E., Elimban, V., Dhalla, N. S., and Netticadan, T. (2003) Elevated levels of protein phosphatase 1 and phosphatase 2A may contribute to cardiac dysfunction in diabetes, Biochim Biophys Acta 1638, 273–277.
Rastogi, S., Sharov, V. G., Mishra, S., Gupta, R. C., Blackburn, B., Belardinelli, L., Stanley, W. C., and Sabbah, H. N. (2008) Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure, Am J Physiol Heart Circ Physiol 295, H2149–H2155.
Zaca, V., Rastogi, S., Imai, M., Wang, M., Sharov, V. G., Jiang, A., Goldstein, S., and Sabbah, H. N. (2007) Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure, J Am Coll Cardiol 50, 551–557.
Kotton, D. N., Summer, R. S., Sun, X., Ma, B. Y., and Fine, A. (2003) Stem cell antigen-1 expression in the pulmonary vascular endothelium, Am J Physiol Lung Cell Mol Physiol 284, L990–L996.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Rastogi, S. (2010). Large Animal Model of Heart Failure for Assessment of Stem Cells. In: Lee, R. (eds) Stem Cells for Myocardial Regeneration. Methods in Molecular Biology, vol 660. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-705-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-60761-705-1_8
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-704-4
Online ISBN: 978-1-60761-705-1
eBook Packages: Springer Protocols